Ventola Cl is a scholar working on Immunology, Pharmacology and Economics and Econometrics.
According to data from OpenAlex, Ventola Cl has authored 11 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Pharmacology and 3 papers in Economics and Econometrics. Recurrent topics in Ventola Cl's work include Pharmaceutical industry and healthcare (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Biosimilars and Bioanalytical Methods (2 papers). Ventola Cl is often cited by papers focused on Pharmaceutical industry and healthcare (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Biosimilars and Bioanalytical Methods (2 papers). Ventola Cl collaborates with scholars based in United States. Ventola Cl's co-authors include and has published in prestigious journals such as PubMed.
In The Last Decade
Ventola Cl
10 papers
receiving
1.1k citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Progress in Nanomedicine: Approved and Investigational Nanodrugs.
This map shows the geographic impact of Ventola Cl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ventola Cl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ventola Cl more than expected).
This network shows the impact of papers produced by Ventola Cl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ventola Cl. The network helps show where Ventola Cl may publish in the future.
No nodes
All Works
11 of 11 papers shown
#
Work
Indexed citations
1
Big Data and Pharmacovigilance: Data Mining for Adverse Drug Events and Interactions.
Current Issues Regarding Complementary and Alternative Medicine (CAM) in the United States: Part 2: Regulatory and Safety Concerns and Proposed Governmental Policy Changes with Respect to Dietary Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.